Simplfying the drug discovery process using target engagement techniques – and how (not) to start up a new research group

Dr Brent Page
UBC Faculty of Pharmaceutical Sciences
Wednesday, July 28, 2021 - 1:00pm Meeting ID: 884 4637 1985 Passcode: 374838
Invited Speaker Seminar
The Page research group focuses on developing novel cancer therapies using innovative chemical biology techniques. Our approach prioritizes the use of cellular target engagement assays that detect direct interactions between potential inhibitors and their intended biological target(s) in cells. Ongoing projects seek to generate promising small molecule inhibitors using cutting-edge medicinal chemistry techniques, and to collaboratively progress these compounds towards advanced preclinical studies.
Raymond Reilly
Centre for Pharmaceutical Oncology